Save time and get answers to complex questions with AI chat
Defense strategy against generic in niche market?Somatuline generic name?Is allopurinol expensive?Dabrafenib btd date 2023?Drugpatentwatch market analysis industry today?
See the DrugPatentWatch profile for Invokana
Date the boxed warning for lower‑limb amputation was removed from Invokana® (canagliflozin): - March 12, 2019 The FDA officially removed the amputation risk from the boxed warning in a labeling update that became effective on that date. The warning had first been added in 2013 after clinical data indicated a higher incidence of lower‑limb amputations in some patients taking canagliflozin.
Other Questions About Invokana :